CNBX Pharmaceuticals, Inc. (CNBX)

0.0001 0.00 (0.00%) USD  |  OTCM  |  Sep 24, 16:00
More

CNBX Pharmaceuticals Cash and Short Term Investments (Quarterly) : 0.0095M for May 31, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CNBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
May 31, 2026 0.0095M
February 28, 2026 0.0122M
November 30, 2025 0.0077M
August 31, 2025 0.0151M
May 31, 2025 0.0136M
February 28, 2025 0.0457M
November 30, 2024 0.0173M
August 31, 2024 0.0264M
May 31, 2024 0.0734M
February 29, 2024 0.0371M
November 30, 2023 0.0816M
August 31, 2023 0.1297M
May 31, 2023 0.0442M
February 28, 2023 0.0477M
November 30, 2022 0.0216M
August 31, 2022 0.1175M
May 31, 2022 0.0963M
February 28, 2022 0.2316M
November 30, 2021 0.7864M
August 31, 2021 1.386M
May 31, 2021 1.968M
February 28, 2021 1.334M
November 30, 2020 0.184M
August 31, 2020 0.7776M
May 31, 2020 1.434M
Date Value
February 29, 2020 2.103M
November 30, 2019 2.810M
August 31, 2019 3.522M
May 31, 2019 4.348M
February 28, 2019 5.168M
November 30, 2018 6.580M
August 31, 2018 1.394M
May 31, 2018 2.215M
February 28, 2018 2.864M
November 30, 2017 2.888M
August 31, 2017 3.368M
May 31, 2017 3.190M
February 28, 2017 0.5672M
November 30, 2016 0.2782M
August 31, 2016 0.0191M
May 31, 2016 0.0885M
February 29, 2016 0.0774M
November 30, 2015 0.0097M
August 31, 2015 0.0252M
May 31, 2015 0.0216M
February 28, 2015 0.0082M
November 30, 2014 0.0656M
August 31, 2014
May 31, 2014 0.00
February 28, 2014 0.0011M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 2.244M
GB Sciences, Inc. --
Arvinas, Inc. 567.90M
Fulcrum Therapeutics, Inc. 318.84M
Definium Therapeutics, Inc. 1.084B